OPTIC NEUROMYELITIS SPECTRUM DISEASE

Clinical trials for OPTIC NEUROMYELITIS SPECTRUM DISEASE explained in plain language.

Never miss a new study

Get alerted when new OPTIC NEUROMYELITIS SPECTRUM DISEASE trials appear

Sign up with your email to follow new studies for OPTIC NEUROMYELITIS SPECTRUM DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial aims to tame rare autoimmune nerve disease

Disease control Ongoing

This study is testing whether an investigational drug called BAT4406F can safely prevent relapses in adults with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the nerves in the eyes and spinal cord. Participants are randomly assigned to re…

Matched conditions: OPTIC NEUROMYELITIS SPECTRUM DISEASE

Phase: PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

OPTIC NEUROMYELITIS SPECTRUM DISEASE

Get alerted when new OPTIC NEUROMYELITIS SPECTRUM DISEASE trials appear

New drug trial aims to tame rare autoimmune nerve disease